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Searchable Question  
Among pre-kindergarten children, does routine tuberculosis screening with lower purified 
protein derivative (PPD) result in morbidity or mortality from tuberculosis than that among 
children who are not routinely screened?  
Evidence-Based Answer  
Routine screening of low-risk children for tuberculosis infection before entering kindergarten is 
not necessary. [Strength of recommendation: C] Targeted screening of high-risk children for 
tuberculosis infection using the intradermal Mantoux test is recommended, but targeted 
screening has not been shown to reduce 
morbidity or mortality. [Strength of 
recommendation: C]  
Evidence Summary  
Routine screening of pre-kindergarten 
children for tuberculosis has been widely 
practiced. However, tuberculosis in this 
age group is uncommon. In 1995, there 
were a little more than 1,500 new cases of 
tuberculosis among young children in the 
United States.1 Many children could 
therefore have a false-positive skin test 
and undergo needless evaluation and 
treatment.2 Current recommendations1,3,4 
suggest that a targeted approach to 
screening is more appropriate, although 
there are no data regarding effects on 
morbidity and mortality in this age group.  
Targeted screening identifies two groups 
of children at high risk of tuberculosis 
infection: (1) children exposed to 
 
Factors Placing Preschool Children at Higher 
Risk of Tuberculosis Infection  
 
Contact with persons who have confirmed or suspected 
tuberculosis 
Immigration from or recent travel to regions where tuberculosis 
is endemic (Asia, Middle East, Africa, Latin America) 
Radiographic or clinical findings consistent with tuberculosis  
Exposure to at-risk persons, such as parents who emigrated from 
regions where tuberculosis is endemic 
Residence in a high-prevalence region 
Immunosuppressive disorders  
 
Information from Preventive services for children and 
adolescents. Bloomington, Minn.: Institute for Clinical Systems 
Improvement, 2003. Accessed February 16, 2004, at 
http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=190.  
 
 
tuberculosis, and (2) children with latent tuberculosis who are at an increased risk of progression 
to active disease and would benefit from treatment of the latent infection.3 [Level of evidence: 5] 
Certain populations are at greater risk (see accompanying table).  
Identifying high-risk children for targeted screening can be accomplished by asking the child's 
parents about risk factors predisposing the child to infection. In a study5 of high-risk children one 
to 18 years of age in southern Bronx, N.Y., targeted screening produced a negative predictive 
value (i.e., the likelihood that children not targeted for screening would have a negative PPD 
result) of 99.8 percent. The positive predictive value (i.e., the probability of a positive PPD result 
among targeted children) remained low, however, because of the low prevalence of positive 
PPDs. [Level of evidence: 1B]  
Children with at least one identifiable risk factor are much more likely to have positive skin-test 
results (odds ratio, 35; 95 percent confidence interval, 12.1 to 102.4). This study did not 
differentiate between pre-kindergarten and older children, although 75 percent of positive PPDs 
occurred in children older than 11 years.  
Cost-benefit analyses confirm the value of targeted screening in children of kindergarten age, 
although no data for younger children are available. In one California study,2 the estimated ratio 
of active tuberculosis cases prevented per 10,000 children in kindergarten who were screened 
improved from 6.4 in the routine-screening group to 74.8 in the targeted-screening group. 
Targeted screening resulted in significant net cost savings and an improved efficiency of the 
screening process. In addition, fewer children with false-positive skin tests required evaluation 
and treatment with potentially harmful medications.2 [Level of evidence: 2C]  
Recommendations from Others  
Practice guidelines and policy statements from the United States Preventive Services Task Force, 
the Centers for Disease Control and Prevention, and the American Academy of Pediatrics 
recommend against routine screening for tuberculosis in children, because the risk of 
tuberculosis infection in the general school-aged population is low, and because false-positive 
results might result in prophylactic treatment with a potentially harmful medication.3,4,6,7 
[References 3, 4, 6, and 7--Level of evidence: 5] The guidelines do recommend screening 
children at high risk.  
Clinical Commentary  
When tuberculosis screening for school-aged children is considered, it seems that less is better. 
New recommendations for pre-kindergarten children are based primarily on consensus 
statements, but the consensus is clear: physicians should target high-risk children. Convincing 
school health officials to adopt a policy of targeted screening may be easier if the task is 
approached according to these consensus recommendations.  
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